Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing Efficacy of 8-Week and 12-Week Faricimab Initial Follow-Up Treatment Intervals Following 4 Loading Doses - Prospective Randomised Study

NCT06875245 is registered in ClinicalTrials.gov with Faculty Hospital Kralovske Vinohrady as lead sponsor.

NCT NCT06875245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06875245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing Efficacy of 8-Week and 12-Week Faricimab Initial Follow-Up Treatment Intervals Following 4 Loading Doses - Prospective Randomised Study
Lead sponsor
Faculty Hospital Kralovske Vinohrady
Phase
Phase 4
Overall status
Recruiting
Start date
March 31, 2023
Completion date
April 30, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

wet age-related macular degeneration